Stay updated on Flotetuzumab EAP in AML: Investigational Clinical Trial
Sign up to get notified when there's something new on the Flotetuzumab EAP in AML: Investigational Clinical Trial page.

Latest updates to the Flotetuzumab EAP in AML: Investigational Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new history revision (v3.3.2) was added and the previous revision (v3.2.0) was removed from the study record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedFunding-status notice at the top of the page was removed and replaced with the standard government-disclaimer banner; no core trial data or functionality appears affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check42 days agoChange DetectedRecord History now reflects updates to the Study Status and Recruitment Status, and notes changes to Locations and Contacts for the NCT04678466 Flotetuzumab Expanded Access Program.SummaryDifference0.1%

- Check71 days agoChange DetectedSignificant changes: added a government operating-status notice and updated to v3.2.0; removed the previous v3.1.0 revision tag. Overall, the page now communicates current operating status and a new version.SummaryDifference13%

- Check78 days agoChange DetectedUpdated the version from v3.0.2 to v3.1.0, indicating a new release without other substantive content changes.SummaryDifference0.3%

- Check92 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.8%

Stay in the know with updates to Flotetuzumab EAP in AML: Investigational Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Flotetuzumab EAP in AML: Investigational Clinical Trial page.